WO2002090525A3 - Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof - Google Patents

Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof Download PDF

Info

Publication number
WO2002090525A3
WO2002090525A3 PCT/US2002/007155 US0207155W WO02090525A3 WO 2002090525 A3 WO2002090525 A3 WO 2002090525A3 US 0207155 W US0207155 W US 0207155W WO 02090525 A3 WO02090525 A3 WO 02090525A3
Authority
WO
WIPO (PCT)
Prior art keywords
kinase proteins
human kinase
nucleic acid
acid molecules
molecules encoding
Prior art date
Application number
PCT/US2002/007155
Other languages
French (fr)
Other versions
WO2002090525A2 (en
Inventor
Marion Webster
Ming-Hui Wei
Chunhua Yan
Francesco Valentina Di
Ellen M Beasley
Original Assignee
Pe Corp Ny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/849,334 external-priority patent/US6500655B1/en
Application filed by Pe Corp Ny filed Critical Pe Corp Ny
Priority to AU2002255680A priority Critical patent/AU2002255680A1/en
Priority to EP02725095A priority patent/EP1385863A2/en
Priority to CA002440575A priority patent/CA2440575A1/en
Publication of WO2002090525A2 publication Critical patent/WO2002090525A2/en
Publication of WO2002090525A3 publication Critical patent/WO2002090525A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01037—Protein kinase (2.7.1.37)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the kinase peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the kinase peptides, and methods of identifying modulators of the kinase peptides.
PCT/US2002/007155 2001-05-07 2002-03-08 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof WO2002090525A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002255680A AU2002255680A1 (en) 2001-05-07 2002-03-08 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
EP02725095A EP1385863A2 (en) 2001-05-07 2002-03-08 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
CA002440575A CA2440575A1 (en) 2001-05-07 2002-03-08 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/849,334 2001-03-07
US09/849,334 US6500655B1 (en) 2001-02-01 2001-05-07 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Publications (2)

Publication Number Publication Date
WO2002090525A2 WO2002090525A2 (en) 2002-11-14
WO2002090525A3 true WO2002090525A3 (en) 2003-03-27

Family

ID=25305581

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/007155 WO2002090525A2 (en) 2001-05-07 2002-03-08 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Country Status (4)

Country Link
EP (1) EP1385863A2 (en)
AU (1) AU2002255680A1 (en)
CA (1) CA2440575A1 (en)
WO (1) WO2002090525A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004251181B2 (en) * 2003-06-27 2009-10-01 Axikin Pharmaceuticals, Inc. Regulation of kinase, 'regulated in COPD kinase' (RC kinase)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018014A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 29 human cancer associated proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018014A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 29 human cancer associated proteins

Also Published As

Publication number Publication date
AU2002255680A1 (en) 2002-11-18
WO2002090525A2 (en) 2002-11-14
CA2440575A1 (en) 2002-11-14
EP1385863A2 (en) 2004-02-04

Similar Documents

Publication Publication Date Title
WO2002077171A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003048303A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2001092496A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002040683A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002016567A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2001088148A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002053717A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003038115A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002068617A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2001090328A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002074974A3 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
WO2002079431A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002081727A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003095612A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002053718A3 (en) Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof
WO2002081654A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002072831A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2003012034A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002057458A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003037910A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002090525A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002077192A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002059288A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002077191A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002052018A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2440575

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002725095

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002725095

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002725095

Country of ref document: EP